Top Markets
Coin of the day
Silverback Therapeutics, Inc. Silverback Therapeutics, Inc.

Silverback Therapeutics, Inc.

SBTX
Rang în acțiuni #12775
Silverback Therapeutics, Inc. operates as a biotechnology firm dedicated to... Silverback Therapeutics, Inc. operates as a biotechnology firm dedicated to devising tissue-specific drug candidates aimed at addressing chronic viral infections, various cancers, and other significant medical conditions. Among its pipeline, SBT8230 stands out as a treatment for chronic hepatitis B virus, working by stimulating an antiviral immune response through the precise activation of TLR8 within the liver. The company was founded in 2016 and maintains its principal offices in Seattle, Washington.
Preț acțiune
$5.87
Ultima sincronizare: 2022-11-08
Capitalizare de piață
$550.43M
Schimbare (1 zi)
1.03%
Schimbare (1 an)
0.00%
Țară
US
Tranzacționează Silverback Therapeutics, Inc. (SBTX)

Categorie

Prețul SBTX cu capitalizarea de piață a B
Silverback Therapeutics, Inc. Silverback Therapeutics, Inc.
SBTX
$5.87
Capitalizarea de piață a Silverback Therapeutics, Inc.(SBTX)
Capitalizare de piață: $550.43M
În anul August 2026, Silverback Therapeutics, Inc. are o capitalizare de piață de $550.43M. Acest lucru face ca Silverback Therapeutics, Inc. să fie a 12775th-a cea mai valoroasă companie din lume, conform datelor noastre. Capitalizarea bursieră reprezintă valoarea totală de piață a acțiunilor în circulație ale unei companii listate și este utilizată frecvent pentru a măsura valoarea unei companii.
Istoricul capitalizării de piață a Silverback Therapeutics, Inc. din 2020 până în 2026
SBTX în comparație cu top 5 cele mai populare stocks
Prețul pentru SBTX Activul B Capitalizarea de piață a B Rezultate
Silverback Therapeutics, Inc. Silverback Therapeutics, Inc.
$56,135.85 $550.43M
$5.264T +956,217.67%
Silverback Therapeutics, Inc. Silverback Therapeutics, Inc.
$50,136.16 $550.43M
$4.701T +854,008.32%
Silverback Therapeutics, Inc. Silverback Therapeutics, Inc.
$44,546.98 $550.43M
$4.177T +758,792.33%
Silverback Therapeutics, Inc. Silverback Therapeutics, Inc.
$40,710.19 $550.43M
$3.817T +693,429.61%
Silverback Therapeutics, Inc. Silverback Therapeutics, Inc.
$30,567.68 $550.43M
$2.866T +520,644.20%